SCHEMBL9517308

SCHEMBL9517308

CC(NC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(COCc3ccccc3)nc2)cc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
KMT2A Q03164 1/20 0.48
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BCL2L1 Q07817 5/20 0.47
MCL1 Q07820 5/20 0.47
P4HTM Q9NXG6 3/20 0.46
MAPK1 P28482 2/20 0.45
PTGER4 P35408 1/20 0.43
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
ROCK2 O75116 1/20 0.42
RPS6KA5 O75582 1/20 0.42
MAP4K4 O95819 1/20 0.42
CDK1 P06493 1/20 0.42
CSF1R P07333 1/20 0.42
PRKACA P17612 1/20 0.42
FLT1 P17948 1/20 0.42
RPS6KB1 P23443 1/20 0.42
CDK2 P24941 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9518145 0.86 P4HTM (0.61) BCL2L1MCL1P4HTM
SCHEMBL9515759 0.84 P4HTM (0.58) ALDH1A1BCL2L1MCL1P4HTMPTGER4
SCHEMBL9516970 0.83 BCL2L1 (0.48) KMT2ASMN1; SMN2BCL2L1MCL1P4HTM
SCHEMBL9517291 0.81 BCL2L1 (0.47) ALDH1A1KMT2ABCL2L1MCL1P4HTM
SCHEMBL9517172 0.79 BCL2L1 (0.50) BCL2L1MCL1P4HTM
SCHEMBL9515532 0.78 P4HTM (0.61) BCL2L1MCL1P4HTM
SCHEMBL9516016 0.76 P4HTM (0.58) BCL2L1MCL1P4HTM
SCHEMBL9518001 0.75 SMN1; SMN2 (0.55) ALDH1A1KMT2AGAASMN1; SMN2P4HTM
SCHEMBL9519274 0.74 SCN3A (0.51) ALDH1A1BCL2L1MCL1P4HTMLMNA
SCHEMBL9517241 0.73 P4HTM (0.61) BCL2L1MCL1P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed